Identification of pterygium-related mRNA expression profiling by microarray analysis

J Liu1, X Ding2, L Yuan1

  • 1Department of Ophthalmology, Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

Insights

This study identified numerous differentially expressed messenger RNAs (mRNAs) in pterygium tissues, revealing their potential role in this ocular surface disease. These findings suggest mRNAs could be new therapeutic targets for pterygium treatment.

Area of Science:

  • Ophthalmology
  • Molecular Biology
  • Genomics

Background:

  • Pterygium is a degenerative ocular surface disease with proliferative characteristics, sometimes leading to visual impairment.
  • Its pathogenesis remains incompletely understood despite similarities to tumorigenesis.
  • Previous research explored long non-coding RNAs (lncRNAs) in pterygium.

Purpose of the Study:

  • To investigate the potential roles of messenger RNAs (mRNAs) in pterygium pathogenesis.
  • To identify differentially expressed mRNAs in pterygium tissues.

Main Methods:

  • Construction of pterygium-related mRNA libraries using microarray analysis.
  • Validation of selected deregulated mRNAs via quantitative real-time PCR (qRT-PCR) in 10 patients.

Main Results:

  • Identification of 1485 upregulated and 2978 downregulated mRNAs in pterygium tissues compared to normal conjunctiva.
  • qRT-PCR confirmed the differential expression of four upregulated and two downregulated mRNAs.

Conclusions:

  • The study reveals distinct mRNA expression profiles in pterygium.
  • These differentially expressed mRNAs represent potential novel molecular targets for pterygium therapy.